What is Corbus Pharmaceuticals Holding (CRBP) stock price today?

Corbus Pharmaceuticals Holding (CRBP) currently trades at $9.82 per share. The stock has a market capitalization of $178.43M and a P/E ratio of —x.

Is CRBP stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Corbus Pharmaceuticals Holding has a Smart Value Score of 27/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

CRBP

Corbus Pharmaceuticals Holding

NASDAQ: CRBP · HEALTHCARE · BIOTECHNOLOGY

$9.82

+0.00% today

Updated 2026-04-29

Market cap

$178.43M

P/E ratio

—

P/S ratio

169.88x

EPS (TTM)

$-5.90

Dividend yield

—

52W range

$6 – $21

Volume

0.2M

Market cap

$178.43M

P/E ratio

—

P/S ratio

169.88x

EPS (TTM)

$-5.90

Dividend yield

—

52W range

$6 – $21

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.7

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$41.25

+320.06%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy8 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-15.93M

- Revenue declining -100.00% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-55.83M	$-44.60M	$-40.21M	$-78.54M	$-20.55M
EPS	—	—	—	—	$-5.90
Free cash flow	$-37.56M	$-36.10M	$-41.79M	$-64.50M	$-15.93M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CRBP	$178.43M	27	3.7	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Corbus Pharmaceuticals Holding trades at $9.82. Our Smart Value Score of 27/100 indicates the stock is weak.

Frequently asked questions

What is Corbus Pharmaceuticals Holding's stock price?

Corbus Pharmaceuticals Holding (CRBP) trades at $9.82.

Is Corbus Pharmaceuticals Holding overvalued?

Smart Value Score 27/100 (Grade F, Strong Sell).

What is the price target of Corbus Pharmaceuticals Holding (CRBP)?

The analyst target price is $41.25, representing +320.1% upside from the current price of $9.82.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio169.88x

ROE-54.20%

Beta2.79

50D MA$9.08

200D MA$10.19

Shares out0.02B

Float0.01B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CRBP vs LLY →CRBP vs JNJ →CRBP vs ABBV →Stock screener →